Glass C, Hipskind P, Tsien C, Malin SK, Kasumov T, Shah SN, Kirwan JP, Dasarathy S. Sarcopenia and a physiologically low respiratory quotient in patients with cirrhosis: a prospective controlled study. J Appl Physiol 114: 559 -565, 2013. First published January 3, 2013 doi:10.1152/japplphysiol.01042.2012.-Patients with cirrhosis have increased gluconeogenesis and fatty acid oxidation that may contribute to a low respiratory quotient (RQ), and this may be linked to sarcopenia and metabolic decompensation when these patients are hospitalized. Therefore, we conducted a prospective study to measure RQ and its impact on skeletal muscle mass, survival, and related complications in hospitalized cirrhotic patients. Fasting RQ and resting energy expenditure (REE) were determined by indirect calorimetry in cirrhotic patients (n ϭ 25), and age, sex, and weight-matched healthy controls (n ϭ 25). Abdominal muscle area was quantified by computed tomography scanning. In cirrhotic patients we also examined the impact of RQ on mortality, repeat hospitalizations, and liver transplantation. Mean RQ in patients with cirrhosis (0.63 Ϯ 0.05) was significantly lower (P Ͻ 0.0001) than healthy matched controls (0.84 Ϯ 0.06). Psoas muscle area in cirrhosis (24.0 Ϯ 6.6 cm 2 ) was significantly (P Ͻ 0.001) lower than in controls (35.9 Ϯ 9.5 cm 2 ). RQ correlated with the reduction in psoas muscle area (r 2 ϭ 0.41; P ϭ 0.01). However, in patients with cirrhosis a reduced RQ did not predict short-term survival or risk of developing complications. When REE was normalized to psoas area, energy expenditure was significantly higher (P Ͻ 0.001) in patients with cirrhosis (66.7 Ϯ 17.8 kcal/cm 2 ) compared with controls (47.7 Ϯ 7.9 kcal/cm 2 ). We conclude that hospitalized patients with cirrhosis have RQs well below the traditional lowest physiological value of 0.69, and this metabolic state is accompanied by reduced skeletal muscle area. Although low RQ does not predict short-term mortality in these patients, it may reflect a decompensated metabolic state that requires careful nutritional management with appropriate consideration for preservation of skeletal muscle mass.
RESPIRATORY QUOTIENT CALCULATED from gas exchange on indirect calorimetry is used to study the relative contribution of different substrates to energy metabolism (21, 43) . RQ is defined as V CO 2 divided by V O 2 (9) . Low respiratory quotient (RQ) has been consistently reported in patients with cirrhosis but its clinical or physiological relevance has not been evaluated in the context of skeletal muscle loss or sarcopenia (21, 34, 40, 41) . Low RQ in patients with cirrhosis has been interpreted as evidence of accelerated starvation (21, 46, 51) . Because starvation is accompanied by impaired skeletal muscle protein synthesis and increased proteolysis, these could potentially contribute to the reduction in skeletal muscle mass or sarcopenia in these patients (8, 10, 11) . During states of starvation, there is a shift in contribution of different substrates to energy generation (3, 32) . In cirrhosis, reduction in RQ occurs early and is more severe compared with healthy subjects (33, 51) . Low RQ in patients with cirrhosis is believed to be a consequence of altered energy metabolism with a rapid switch in substrates from carbohydrate to fatty acid oxidation and gluconeogenesis from amino acids (2, 4, 19) . Theoretical and experimental evidence using calorimetry has shown that the RQ from the three major substrates for energy are different (9) . The lowest physiological RQ is considered to be 0.69 based on the assumption that the entire energy cost is derived from the oxidation of fatty acids. It has also been suggested that measured RQs less than 0.65 are due to methodological errors (18) . There are few reports on measured RQs less than 0.69 (6) . In the liver, ketogenesis, which is an incomplete oxidation of fatty acids, will decrease the RQ and gluconeogenesis, which incorporates carbon that can potentially lower the RQ to values much lower than 0.69 (45) . Reduced hepatic RQ due to accelerated ketogenesis and gluconeogenesis is counterbalanced by the complete oxidation of these metabolites in nonhepatic tissue, resulting in whole body RQ that may be lower than the predicted RQ based on substrate oxidation.
Cirrhosis is characterized by reduced hepatic glycogen content (2, 17, 36) and insulin resistance (2, 20, 30, 42) . Both of these metabolic responses exaggerate ketogenesis and gluconeogenesis that can lower the hepatic RQ to values below 0.69 (2, 4, 36) . Whole body RQ, however, is the net of hepatic and nonhepatic RQ. When ketones and glucose are completely oxidized in the periphery, primarily in skeletal muscle, this RQ is 1.0, thereby increasing the whole body RQ (15, 32) . However, when the skeletal muscle mass is reduced as occurs in cirrhosis (35) , it is likely to result in incomplete oxidation of ketones. This will increase the relative contribution of the very low hepatic RQ to net whole body RQ. This can potentially explain abnormally low whole body RQs that have previously been considered to be due to methodological errors (18) . Previous reports on patients with cirrhosis to study energy metabolism have been done only in stable, outpatient populations (21, 34, 40, 43, 48) . Hospitalized patients with cirrhosis have a greater severity of illness and are therefore likely to be metabolically decompensated in terms of substrate contribution to energy production.
We hypothesized that hospitalized patients with cirrhosis are more likely to have significantly lower RQs than have been previously reported. We also hypothesized that the reduction in RQ would be accompanied by loss of skeletal muscle. A prospective study was performed to quantify RQ in these patients and relate the outcome to abdominal muscle mass measured by CT scanning using our previously established methodology (52) .
METHODS

Subjects.
Consecutive adult hospitalized cirrhotic patients (n ϭ 25) were included in this prospective study. Some of the clinical and demographic details of the patients with cirrhosis have been published elsewhere because they were part of an ongoing prospective study on energy metabolism in cirrhosis (12) . All patients were on a standard hospital diet with a 2 g sodium but no protein restriction. No other dietary alterations were made to the patients' meals. No patient received enteral or parenteral nutrition. A simultaneous cohort of healthy subjects who were age, sex, and body mass index matched (n ϭ 25) formed the control population. All free living controls were allowed to eat their usual diet. Because it was difficult to match the dietary intake of hospitalized patients with cirrhosis with that of outpatient, healthy controls, we ensured that the duration of fasting before quantifying RQ and REE was similar. Patients with uncontrolled diabetes mellitus, renal failure on dialysis, medications or supplements that affected skeletal muscle mass, advanced malignancies, end stage organ failure other than cirrhosis were excluded. Cirrhotic patients were followed up after discharge to determine their outcomes. After an overnight fast, blood glucose, serum amino transferases, blood urea nitrogen, serum creatinine, albumin, and bilirubin were obtained on the day of the study in the clinical core laboratory. Child-Pugh and the model for end stage liver disease (MELD scores) were calculated for the cirrhotic subjects (16) . Urinary ketones were measured in the first morning sample in all subjects.
Indirect calorimetry. The V O2 and V CO2 were quantified using an open canopy indirect calorimeter (Vmax Encore, Viasys, Yorba Linda, CA) in the clinical research unit as previously described (12) . In brief, patients were allowed to rest for 10 min prior to the determination of substrate oxidation and energy expenditure. Breath samples were collected for a total of 15 min, and only the last 5 min were used for analysis. The calorimeter was calibrated prior to each study and was carefully checked for any leaks. All cirrhotic patients also had breath samples analyzed by a hand held respiratory calorimeter (MedGem, Microlife, Golden, CO) either preceding or following the indirect calorimetry. Resting energy expenditure (REE) was also calculated for all study participants using the Harris Benedict equations (14) . Cirrhotic patients were classified as hypermetabolic when the measured REE exceeded the predicted values by over 20% of that predicted by the Harris Benedict equation and hypometabolic when the measured REE was reduced by 20% of the predicted value (27) . The predictive values were generated using both actual measured body weight as well as the estimated ideal body weight using the Hamwi formula (13) .
Body weight. Anthropometric measurements (whole body weight, height) were obtained in a standard hospital gown on a calibrated scale and a wall-mounted stadiometer. Body mass index (BMI) was calculated as body mass (kg) divided by height (m 2 ). Measurement of muscle area. Appendicular muscle areas were measured on a Leonardo Workstation using Oncocare (Seimens Healthcare, Erlangen, Germany) as previously described (52) . In brief, unenhanced axial CT scans at the mid fourth lumbar vertebral level were used to determine the cross-sectional area and mean attenuation (in Hounsfield units) of the major and minor psoas and paraspinal muscles on both sides as well as the total abdominal wall muscles. Subcutaneous and visceral adipose tissue mass were quantified. All CT scans had been performed as part of clinical care of these patients. Use of single slice CT images to quantify muscle and fat area as a reflection of whole body measure of skeletal muscle and adipose tissue has been previously reported by others and is considered a standard method to quantify skeletal muscle and fat mass (23, 47) .
All studies were approved by the Institutional Review Board at the Cleveland Clinic, and written informed consent was obtained from all subjects.
Statistical analyses. Qualitative variables were compared using the Chi square test and quantitative variables compared using the Student's t-test. Correlations were determined using the Pearson's correlation coefficient. Patients were followed up after the study till they died or the date of last follow-up. Multivariate analysis was performed to examine the relation between RQ and psoas area and visceral fat mass. All values were expressed as mean Ϯ standard deviation unless otherwise specified. A P value Ͻ0.05 was considered statistically significant. On the basis of previous data of an anticipated difference of at least 35% in measured RQ between patients with cirrhosis and controls, an ␣ of 5% and a power of 80%, we required at least 11 subjects in each study group. All analyses were performed using SPSS 20.0 (IBM, Armonk, NY).
RESULTS
Clinical characteristics.
Clinical and demographic features of cirrhotic patients and controls are shown in Table 1 . The reasons for hospitalization were infection (n ϭ 6), encephalopathy (n ϭ 8), renal failure (n ϭ 3), ascites (n ϭ 3), and other causes (n ϭ 5). Ten of these patients had well-controlled diabetes mellitus (HbA1C 6.4 Ϯ 1.4 g/dl). As expected, the biochemical parameters (serum bilirubin, albumin, and coagu- lation profile) in patients with cirrhosis were abnormal because all of them were hospitalized and decompensated (12) . Trace urinary ketones were present in 5 (20%) patients with cirrhosis. The laboratory tests in the healthy controls were within normal limits ( Table 2) .
Energy metabolism. Cirrhotic subjects had significantly lower (P Ͻ 0.01) RQ compared with healthy age, BMI and sex matched healthy controls (Fig. 1) . Of the 25 patients with cirrhosis, 20 patients had an RQ less than 0.68. Although this group was considered to be metabolically decompensated, their Child-Pugh and MELD scores were not significantly different from those with RQ values greater than 0.68 (Table 3) . Similarly their renal functions were also not different. Methodological errors contributing to nonphysiological RQs in patients with cirrhosis were excluded by comparing the V O 2 measured by the metabolic cart with that obtained from the HHRC. Because V O 2 measured using both the metabolic cart and the HHRC were nearly identical (233.1 Ϯ 45.5 vs. 220.2 Ϯ 44.0 ml/min) (12) , it suggests that our RQ measurements were accurate and reliable. Furthermore, in a contemporaneous cohort of healthy subjects using the same metabolic cart, the RQs obtained were within the normal expected range. Laboratory values of severity of liver disease, including serum bilirubin, albumin, prothrombin time, creatinine, and blood urea nitrogen, did not correlate with measured RQ or reduction in RQ in patients with cirrhosis. The mean RQ was significantly lower (P ϭ 0.02) in the five patients with trace urinary ketones (RQ ϭ 0.58 Ϯ 0.03) compared with the remaining 20 in whom urinary ketones were absent (RQ ϭ 0.64 Ϯ 0.05).
The REE in patients with cirrhosis (1,525.6 Ϯ 305.3 kcal/ day) was similar to that in controls (1,571.2 Ϯ 278.3 kcal/day). REE estimated by the Harris Benedict equation in patients with cirrhosis using either the actual measured weight (1,711.6 Ϯ 293.9) or the predicted ideal body weight (1,510.2 Ϯ 223.4) showed no significant difference (P Ͼ 0.1). By using the conventional methods to classify patients with cirrhosis based on REE, there were 3 (12%) hypermetabolic, 7 (28%) hypometabolic, and 15 (60%) eumetabolic patients with cirrhosis.
Skeletal muscle in cirrhosis. Abdominal muscle area was significantly lower in patients with cirrhosis compared with controls (Table 4) . Skeletal muscle density was also significantly lower in patients with cirrhosis than controls but did not correlate with RQ. BMI did not correlate with RQ either in controls or in patients with cirrhosis. However, psoas muscle area correlated (r 2 ϭ 0.69; P Ͻ 0.001) highly with the RQ in the study subjects (Fig. 2) . Patients with cirrhosis had lower muscle area and lower RQ compared with controls. However, in the cirrhotic patients alone, RQ did not correlate with muscle area.
REE showed a positive correlation with psoas muscle area in both groups (Fig. 3) . Despite no difference in mean REE in the two groups, mean REE normalized to psoas area was significantly higher (P ϭ 0.002) in patients with cirrhosis compared with controls (Fig. 4) . These relations were maintained when the other groups of muscle were used (data not shown).
Fat mass in cirrhosis. Both visceral and subcutaneous fat mass were significantly lower in patients with cirrhosis compared with controls (Table 4 ; P Ͻ 0.05). Both visceral fat mass (r 2 ϭ 0.39; P ϭ 0.01) and subcutaneous fat mass (r 2 ϭ 0.46; P ϭ 0.01) correlated significantly with the RQ (Figs. 5 and 6 ). There was no significant correlation between fat mass (visceral or subcutaneous) and the measured or predicted REE. Multivariate analysis with RQ as the dependent variable showed a significant relation with psoas muscle area (P ϭ 0.038) and a trend effect for visceral fat mass (P ϭ 0.058). Outcomes. Of the 25 patients with cirrhosis included in the study, 11 (44%) died and 7 (28%) underwent liver transplantation over a period of 10.9 Ϯ 5.2 mo of follow up. Twentythree patients were readmitted (3.7 Ϯ 2.7 hospitalizations) during follow up. RQ did not correlate with short-term outpatient survival in these patients with cirrhosis (Table 5) . Readmission rates and postdischarge development of other complications, including renal failure, GI bleed, and encephalopathy, also did not correlate with the degree of reduction in RQ. Metabolic status based on REE (hyper or hypometabolic) and REE normalized to psoas area were also similar in patients with cirrhosis who survived and those who died.
DISCUSSION
The novel finding in this study is that very low whole body RQs occur in hospitalized, decompensated, cirrhotic patients. Skeletal muscle mass, measured as psoas and other abdominal muscle areas, was significantly lower in patients with cirrhosis than controls. RQ correlated highly and directly with the skeletal muscle area. Although resting energy expenditure in patients with cirrhosis was similar to that in controls, when normalized for muscle area, patients with cirrhosis had much higher REE than controls. An additional observation in this study was that the reduction in RQ was also accompanied by lower visceral and subcutaneous fat mass compared with controls. The degree of reduction in RQ did not predict either in-hospital or short-term adverse outcomes. Finally, worsening severity of liver disease measured by Child's score or MELD score was not associated with greater decline in RQ.
Low RQ in cirrhosis has been reported by a number of authors in the past and is believed to be due to an altered energy metabolism characterized by a switch to fatty acids and gluconeogenic substrates (31, 33, 39, 46) . These metabolic alterations are considered to be the consequence of both hepatocellular dysfunction and portacaval shunting (31) . Because hepatic glycogen content is decreased in cirrhosis (2, 17, 33) , there is a greater need for increased noncarbohydrate-derived substrate oxidation to meet the bioenergetic demands of these patients. To accommodate the increased energy needs, fatty acid oxidation and gluconeogenesis (requiring the carbon skeleton from muscle protein derived amino acids) are increased in these patients (21, 26, 28, 29, 36) . These responses are accompanied by a reduction in measured RQ (21) . Consistent with these anticipated metabolic responses, we observed much lower RQ than has been predicted (RQ values of 0.69 or higher) based on estimated contributions of different substrates to the oxidative metabolism (9, 18) . Previous studies have reported increased gluconeogenesis and ketogenesis in patients with cirrhosis and this may be the reason for these unexpected values in this study (2, 31, 33, 36, 39, 50) . The trace urinary ketones in patients with very low RQ support our interpretation that the very low RQ is partially accounted for by increased ketogenesis in these patients. Although we cannot address the exact mechanisms responsible for these very low RQ values in the present study, patients with the trace ketones were not diabetic and all our patients with diabetes had good glycemic control. Because gluconeogenesis was not quantified, its contribution to the reduction in RQ cannot be determined in these patients. Our data do, however, suggest that detailed metabolic studies using isotopic tracers in decompensated patients with cirrhosis are required to examine the mechanisms of these metabolic responses.
Whole body RQ is determined by the contribution of the metabolism of individual organs (24) . It has been suggested that the liver contributes to 20 -30% of whole body energy expenditure at rest (24) . Because hepatic substrate utilization is altered in cirrhosis due to depletion of glycogen stored and increased fatty acid oxidation, the hepatic RQ is anticipated to be lower than the whole body RQ. The contribution of hepatic RQ to whole body RQ is also determined by the relative contribution of other organs like the skeletal muscle (24) . Because skeletal muscle completely oxidizes ketones and is not gluconeogenic (37, 38) , its RQ is higher than that of the liver. If the skeletal muscle mass was unaltered, then its contribution to whole body RQ would be increased in patients with cirrhosis, resulting in higher RQs than are observed in the present study. However, skeletal muscle area was significantly lower in patients with cirrhosis than controls, and this observation is similar to that previously reported by us and others (7, 22, 52) . As a consequence, the contribution of skeletal muscle metabolism to whole body RQ is likely to result in a reduction in whole body RQs. Very low RQ in this population of patients with cirrhosis may therefore be a response to the skeletal muscle depletion along with increased hepatic gluconeogenesis and ketogenesis. This is similar to the altered skeletal muscle ketone metabolism described in cardiac failure (15) , another common condition characterized by sarcopenia. Skeletal muscle attenuation was lower in patients with cirrhosis compared with controls that was similar to our previous report (52) . However, skeletal muscle density measured by CT was not predictive of outcome and its physiological significance in cirrhosis needs to be evaluated.
Quantification of urinary nitrogen helps in determining the contribution of different substrates to whole body metabolism (21) . In the present study, urinary nitrogen was not quantified, but our direct measurements of muscle area show that the lower RQ is accompanied by lower muscle area. Another interpretation of our observations is that skeletal muscle de- rived amino acids to gluconeogenesis contribute to sarcopenia in these patients. However, it is possible that the low RQ may not be directly responsible for the reduction in muscle mass, rather, it may be due to the metabolic perturbations that result in a low RQ.
Consistent with the contribution of increased fatty acid oxidation to the reduction in RQ in cirrhosis, we observed a reduction in both visceral and subcutaneous fat mass measured on imaging. These observations are similar to those we have reported earlier in a separate cohort of patients with cirrhosis who had lower visceral fat mass (52) . This is also consistent with the trace ketonuria seen in these patients. Our observations, however, only show an association between the low RQ and fat mass and more detailed direct metabolic kinetic studies using tracers will be necessary to demonstrate that the low fat mass in cirrhosis is accompanied by increased fatty acid oxidation and consequent low RQ (19) . It was interesting that on multivariate analysis, psoas muscle area had a significant independent effect on RQ, whereas fat mass showed only a trend to altering RQ. Our studies also do not permit us to examine the differential contribution of increased gluconeogenesis, ketogenesis, and fatty acid oxidation to the lower RQ and such studies are necessary to design targeted interventions to reverse these metabolic abnormalities in cirrhosis. In the present studies, we used CT images at L4 vertebra as estimates of whole body fat and muscle mass because these have been shown by others to be a valid measure of whole body fat and muscle mass (23, 47) . Although REE in this group of patients with cirrhosis was similar to that in controls and only 12% could be considered hypermetabolic, patients with cirrhosis had a significantly higher mean REE normalized to muscle area. Because skeletal muscle is the largest metabolically active organ, normalizing for muscle area showed that these patients appear to have a higher metabolic demand due to the contribution from other organs (1, 25) . Loss of muscle mass with hypermetabolism has been reported in chronic renal failure, chronic obstructive lung disease, and congestive heart failure (5, 44, 49, 53, 54) . However, the relation between RQ and body composition in these patients has not been studied in detail. Our data suggest that similar metabolic studies to quantify the contribution of substrate dysmetabolism may provide potential targets and outcome measures to study the response to interventions to reverse sarcopenia.
Such a severe derangement in energy metabolism is expected to result in adverse outcomes. RQ values Ͻ0.85 has been previously reported to increase mortality over a long-term period (48) . Our studies, however, did not demonstrate such an adverse effect on survival during the shorter period of follow up in patients with cirrhosis. Because all the patients with cirrhosis in our study had RQs Ͻ0.85, the ability of RQ to predict outcome may have been lost. This may reflect a threshold effect where, after a certain degree of metabolic perturbation has occurred, the outcome is determined by the whole body compensatory processes that may not necessarily alter the measured RQ. This may also explain the absence of more severe muscle loss in patients with RQ Ͻ0.68 compared with those with an RQ Ͼ0.68 because the majority of our patients had a very low RQ. The relation between RQ and muscle area, however, became evident when this was examined in both patients with cirrhosis and control subjects because the RQ was no longer restricted to a very narrow range as it was in the patients with cirrhosis alone. Interestingly, in the present study, we did not observe a difference in muscle area between survivors and nonsurvivors. This is different from that previously reported in nonhospitalized, free living patients with cirrhosis (22) . This may be due to differences in the metabolic and other clinical characteristics of the patients in the present study.
In conclusion, we demonstrate for the first time that low RQs below 0.69 occur in advanced liver disease and do not necessarily predict mortality. The direct and significant relation between RQ and muscle area suggests that altered skeletal muscle protein turnover contributes to this metabolic response. In vivo studies of individual organ contributions specifically focusing on skeletal muscle contribution to substrate utilization patterns in cirrhosis may provide the basis for specific interventions to reverse the reduced muscle mass in these patients.
